Clinical Trials and Cancer Immunotherapy: Accessing Promising Treatments

Myth-busting patient participation in medical studies. Clinical trials are essential to bringing promising new therapies to patients, often for the first time or in new combinations with other treatments. What is a clinical trial? What are common misconceptions about clinical trials? How can you access and enroll in a cancer immunotherapy clinical trial? How has the COVID-19 pandemic changed patient participation in cancer clinical trials? These are just a few of the questions that Dr. Peter Fecci, Professor of Neurosurgery, Pathology, Immunology, and Biomedical Engineering at Duke University, will address during this informative and myth-busting session. Following his talk, you’ll have an opportunity to ask your questions about clinical trials during a live Q&A session.

[ginavilla]

How many types of biopsies are there to have a diagnosis of a tumor?